High Court Asked To Review Nixed $600M Stent IP Verdict
A New Jersey radiologist has urged the U.S. Supreme Court to review the Federal Circuit's finding that Johnson & Johnson didn't infringe the doctor's stent patent, a ruling that wiped out...To view the full article, register now.
Already a subscriber? Click here to view full article